The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Postoperative Levonorgestrel-Releasing Intrauterine System for Pelvic Endometriosis-Related Pain: A Randomized Controlled Trial
Abstract
OBJECTIVES: To estimate the effectiveness of a postoperative levonorgestrel-releasing intrauterine system for relieving pelvic pain in patients with endometriosis. METHODS: A double-blind randomized controlled trial was conducted in 55 patients with endometriosis and moderate-to-severe dysmenorrhea (visual analog scale, greater than 50 mm) undergoing laparoscopic conservative surgery. After surgery, patients were randomized to a levonorgestrel-releasing intrauterine system (n=28) or expectant management (n=27) group. Primary outcome was the change of dysmenorrhea visual analog scale. Secondary outcomes included changes of pelvic pain and dyspareunia visual analog scale, Short Form-36 score, and adverse effects. RESULTS: The two groups were comparable in age, body mass index, parity, and baseline pain scores. At 12 months, the levonorgestrel-releasing intrauterine system group had a significantly lower median value of dysmenorrhea and noncyclic pelvic pain score. Compared with the control group, the levonorgestrel-releasing intrauterine system group had greater reduction in dysmenorrhea visual analog scale (-81.0 compared with -50.0 mm, P=.006) and pelvic pain visual analog scale (-48.5 compared with -22.0 mm, P=.038) but a comparable reduction in dyspareunia visual analog scale (-15.0 compared with -19.0 mm, P=.831). Two patients in levonorgestrel-releasing intrauterine system group (7.4%) and nine in the expectant management group (39.1%) had recurrent dysmenorrhea within 1 year postoperatively (P=.014). Number-needed-to-treat to prevent one case with recurrent dysmenorrhea within the first year was three cases. The Short Form-36 scores improved in the levonorgestrel-releasing intrauterine system group but did not change in the expectant management group. There was no serious adverse event during the study period. CONCLUSION: The levonorgestrel-releasing intrauterine system is effective and well accepted for long-term therapy after conservative surgery for patients with moderate to severe pain related to endometriosis. It can improve the patient's quality of life, including physical and mental health.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, LNG-IUS use after surgery was associated with a significantly lower dysmenorrhea recurrence rate compared to with expectant management [231–233].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [233]
In the citing paper
“These outcomes are superimposable to those obtained by Tanmahasamut et al. [83], that did not identify any endometrioma recurrence after 12 months of Accepted Manuscript treatment with LNG-IUS.”
From Oral and depot progestin therapy for endometriosis: towards a personalized medicine (2017) · cites this paper as [83]
In the citing paper
“Progestins were positively associated with HRQoL in women with endometriosis [20,21,23-25,27,29,30].”
From Health-related quality of life in women with endometriosis: a systematic review (2012) · cites this paper as [30]
In the citing paper
“Postoperative levonorgestrel intrauterine system (LNG-IUS) for 12 months improved both physical and mental health for women with moderate to severe pain related to endometriosis [30], although inconsistent finding was reported, possibly due to low sensitivity of the PGWBI questionnaire applied [23].”
From Health-related quality of life in women with endometriosis: a systematic review (2012) · cites this paper as [30]
Citations
Cites
Petta, C. A., Ferriani, R. A., Abrao, M. S., Hassan, D., Rosa e Silva, J. C., Podgaec, S., & Bahamondes, L. (2005) · Human Reproduction · doi:10.1093/humrep/deh869 · Cited by 363
Probability plotting methods for the analysis for the analysis of data
WILK, M. B., & GNANADESIKAN, R. (1968) · Biometrika · doi:10.1093/biomet/55.1.1 · Cited by 278
Treatment of severe postmenopausal endometriosis with an aromatase inhibitor
Takayama, K., Zeitoun, K., Gunby, R. T., Sasano, H., Carr, B. R., & Bulun, S. E. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00022-3 · Cited by 270
Vercellini, P., Frontino, G., De Giorgi, O., Aimi, G., Zaina, B., & Crosignani, P. G. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00608-3 · Cited by 263
Sutton, C. J. G., Pooley, A. S., Ewen, S. P., & Haines, P. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00403-2 · Cited by 250
Ailawadi, R. K., Jobanputra, S., Kataria, M., Gurates, B., & Bulun, S. E. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.09.029 · Cited by 236
Levonorgestrel-Releasing Intrauterine Device
Luukkainen, T., Lähteenmäki, P., & Toivonen, J. (1990) · Annals of Medicine · doi:10.3109/07853899009147248 · Cited by 207
Vercellini, P., Aimi, G., Panazza, S., De Giorgi, O., Pesole, A., & Crosignani, P. G. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00291-5 · Cited by 169
Lockhat, F. B., Emembolu, J. O., & Konje, J. C. (2005) · Human Reproduction · doi:10.1093/humrep/deh650 · Cited by 166
Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis
Hornstein, M. D., Hemmings, R., Yuzpe, A. A., & Heinrichs, W. L. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00360-9 · Cited by 155
Research works printed but not linked: 5
- Lin, 2001, J Formos Med Assoc, 100, 466
- Du, 1999, Zhonghua Fu Chan Ke Za Zhi, 34, 363
- Luciano, 1988, Obstet Gynecol, 72, 323
- Wilk, 1968, Biometrika, 55, 1
- Marques, 2004, J Reprod Med, 49, 115
Cited by
ESHRE guideline: endometriosis
Becker, C. M., Bokor, A., Heikinheimo, O., Horne, A., Jansen, F., Kiesel, L., King, K., Kvaskoff, M., Nap, A., Petersen, K., et al. (2022) · Human Reproduction Open · doi:10.1093/hropen/hoac009 · Cited by 1,712
“Women may be offered postoperative hormone treat-ment to improve the immediate outcome of surgery for pain in women with endometriosis if not desiring immediate pregnancy (Tanmahasamut et al. , 2012; Chen et al. , 2020).”
Rethinking mechanisms, diagnosis and management of endometriosis
Chapron, C., Marcellin, L., Borghese, B., & Santulli, P. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0245-z · Cited by 1,084
Systematic review of endometriosis pain assessment: how to choose a scale?
Bourdel, N., Alves, J., Pickering, G., Ramilo, I., Roman, H., & Canis, M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu046 · Cited by 372
RETIRED: No. 345-Primary Dysmenorrhea Consensus Guideline
Burnett, M., & Lemyre, M. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2016.12.023 · Cited by 332
Hormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
Metadata
- Authors
- Tanmahasamut, P., Rattanachaiyanont, M., Angsuwathana, S., Techatraisak, K., Indhavivadhana, S., & Leerasiri, P.
- Affiliations
- Siriraj Hospital (TH)
- ORCID
- Venue
- Obstetrics & Gynecology
- Published
- 2012-03
- Volume
- 119
- Issue
- 3
- Pages
- 519-526
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2022191811
- Cited by
- 105
- References
- 30
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 5 · 2023: 4 · 2022: 6 · 2021: 9 · 2020: 7 · 2019: 4 · 2018: 11 · 2017: 13 · 2016: 8 · 2015: 8 · 2014: 4 · 2013: 13 · 2012: 4
- FWCI
- 10.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- levonorgestrel-releasing intrauterine system, pelvic endometriosis, dysmenorrhea, postoperative pain management, laparoscopic conservative surgery, expectant management, dyspareunia, quality of life, long-term hormonal therapy
- MeSH terms
- Adult, Contraceptive Agents, Female, Double-Blind Method, Dysmenorrhea, Endometriosis, Female, Humans, Intrauterine Devices, Medicated, Laparoscopy, Quality of Life, Severity of Illness Index, Levonorgestrel, Pelvic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Postoperative Levonorgestrel-Releasing Intrauterine System for Pelvic Endometriosis-Related Pain: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.1097/aog.0b013e31824264c3
- The paper
- Tanmahasamut, P., Rattanachaiyanont, M., Angsuwathana, S., Techatraisak, K., Indhavivadhana, S., & Leerasiri, P. (2012). Postoperative Levonorgestrel-Releasing Intrauterine System for Pelvic Endometriosis-Related Pain: A Randomized Controlled Trial. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0b013e31824264c3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.